Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Integrin αIIIa Inhibitors

Integrin αIIIa inhibitors are a class of chemical compounds that specifically target the integrin αIIIa, a subunit of the integrin family of cell surface receptors involved in cell adhesion, migration, and signaling. Integrins are heterodimeric proteins, meaning they are composed of two distinct subunits: an alpha (α) and a beta (β) subunit. These receptors play crucial roles in connecting cells to the extracellular matrix (ECM) and facilitating interactions between cells and their surrounding environment. Integrin αIIIa is typically paired with specific β subunits to form functional receptors that mediate binding to ligands such as fibrinogen, fibronectin, and other components of the ECM. By doing so, integrin αIIIa is involved in regulating cellular adhesion, shape, and migration, influencing processes such as wound healing, tissue remodeling, and immune responses. Inhibitors of integrin αIIIa are designed to block these interactions, altering the integrin's ability to mediate such cellular processes.

The design of integrin αIIIa inhibitors focuses on disrupting the specific binding sites within the αIIIa subunit that are essential for its interactions with ligands or other ECM components. These inhibitors may function by binding to the receptor's active site, preventing the conformational changes necessary for integrin activation, or by occupying the ligand-binding pocket, thereby blocking the attachment of ECM molecules. The interaction between integrin αIIIa inhibitors and the receptor is often mediated by non-covalent forces such as hydrogen bonds, van der Waals interactions, and hydrophobic interactions, ensuring specific and stable binding. By inhibiting integrin αIIIa, researchers can explore how this integrin regulates cellular adhesion and migration, providing deeper insights into the role of integrins in maintaining tissue architecture and facilitating communication between cells and their microenvironment. These inhibitors are valuable tools for studying integrin-mediated cellular behaviors and how integrin dysfunction can affect broader biological systems.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD 98059 could inhibit ITGA3 expression by blocking the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway, which is often involved in the transcriptional control of integrin genes.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 might lead to the decrease in ITGA3 expression by specifically inhibiting c-Jun N-terminal kinase (JNK), which can be necessary for the activation of transcription factors that upregulate ITGA3.